Peginterferon plus ribavirin for hepatitis C in HIV-infected patients [2] (multiple letters)

New England Journal of Medicine

Volumn 351, Issue 22, 2004, Pages 2340-2342

  Taylor, Lynn E ^a   Rich, Josiah D ^a   Tashima, Karen T ^a   Gholam, Pierre M ^a   Torriani, Francesca J ^b   Dieterich, Douglas T ^c   Chung, Raymond T ^d   Andersen, Janet ^e   Volberding, Paul ^f  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PEGINTERFERON; RIBAVIRIN; ALPHA2A INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; PEGINTERFERON ALPHA2A;

BODY MASS; CELL COUNT; DOSE RESPONSE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; RACE; RELAPSE; TREATMENT OUTCOME; VIRULENCE; DRUG COMBINATION; ETHNOLOGY; GENETICS; NOTE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; IMMUNOLOGY;

ANTIVIRAL AGENTS; BODY MASS INDEX; DRUG THERAPY, COMBINATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERON ALFA-2A; POLYETHYLENE GLYCOLS; RIBAVIRIN; ACQUIRED IMMUNODEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT;

EID: 13644262060     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200411253512220     Document Type: Letter

References (0)